R. Walters

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.

G. Hortobagyi, N. Sneige, V. Valero, 2011, The oncologist.

A Phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma

G. Hortobagyi, F. Ames, V. Valero, 2003, Cancer.

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Terry L. Smith, D. Berry, G. Hortobagyi, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

G. Hortobagyi, V. Valero, D. Booser, 2000, Cancer.

Phase I trail of droloxifene in patients with metastatic breast cancer

G. Hortobagyi, D. Booser, R. Theriault, 2004, Cancer Chemotherapy and Pharmacology.

Fluorouracil, Doxorubicin, and Cyclophosphamide Followed by Tamoxifen as Adjuvant Treatment for Patients with Stage IV Breast Cancer with No Evidence of Disease

G. Hortobagyi, R. Theriault, A. Buzdar, 2002, The breast journal.

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer

G. Hortobagyi, D. Booser, A. González-Angulo, 2007, Cancer Chemotherapy and Pharmacology.

The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.

Terry L. Smith, G. Hortobagyi, S. Singletary, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.

G. Hortobagyi, L. Pusztai, V. Valero, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.